F-2(PMP)(2)-TAM-ZETA(3), A NOVEL COMPETITIVE INHIBITOR OF THE BINDINGOF ZAP-70 TO THE T-CELL ANTIGEN RECEPTOR, BLOCKS EARLY T-CELL SIGNALING

Citation
Rl. Wange et al., F-2(PMP)(2)-TAM-ZETA(3), A NOVEL COMPETITIVE INHIBITOR OF THE BINDINGOF ZAP-70 TO THE T-CELL ANTIGEN RECEPTOR, BLOCKS EARLY T-CELL SIGNALING, The Journal of biological chemistry, 270(2), 1995, pp. 944-948
Citations number
43
Categorie Soggetti
Biology
ISSN journal
00219258
Volume
270
Issue
2
Year of publication
1995
Pages
944 - 948
Database
ISI
SICI code
0021-9258(1995)270:2<944:FANCIO>2.0.ZU;2-O
Abstract
Signaling by the T cell antigen receptor (TCR) is mediated by 17-resid ue tyrosine-based activation motifs (TAM) present in the cytoplasmic t ails of the TCR zeta and CD3 chains. TAMs become tyrosine-phosphorylat ed upon TCR stimulation, creating a high affinity binding site for the tandem SH2 domains of ZAP-70. In permeabilized T cells, the associati on of TCR and ZAP-70 was inhibited by a protein tyrosine phosphatase ( PTPase)resistant TAM peptide analog, in which difluorophosphonomethyl phenylalanyl (F(2)Pmp) residues replaced phosphotyrosine. Inhibition o f this association prevented TCR-stimulated tyrosine phosphorylation o f ZAP-70 and reduced ZAP-70 kinase activity to basal levels. The reduc tion in ZAP-70 activity coincided with reduced tyrosine phosphorylatio n of a number of substrates. Such PTPase-resistant peptides, capable o f disrupting SH2 domain-mediated protein-protein interactions, should prove useful in further dissection of multiple signaling pathways and may serve as models for rationally designed chemotherapeutic agents fo r the treatment of autoimmune and neoplastic disorders.